-
Conference Attendees Learn that Keytruda Yields Disappointing Mesothelioma Results
Keytruda is an immunotherapy protocol that has proven remarkably effective in treating many types of cancer, but attendees at an international cancer conference learned this week that a randomized phase 3 trial showed disappointing results in mesothelioma patients.
-
For Best Mesothelioma Outcomes, Patients Need Specialized, Experienced Treatment
Every cancer diagnosis is serious and requires immediate and experienced medical attention, but when it comes to treating malignant mesothelioma, it is essential that patients get the right care. A new study published in the Annals of Thoracic Surgery has revealed an enormous difference in median survival outcomes between patients who are treated at low-volume cancer…
-
Judge Rejects J&J’s Bid to Avoid Paying Award to Deceased Mesothelioma Victim
Last June, a jury in California found Johnson & Johnson, Colgate-Palmolive and Avon Products jointly liable for Patricia Schmitz’s malignant mesothelioma, and awarded the woman $2 million in economic damages and another $10 million in noneconomic damages. One month later Mrs. Schmitz succumbed to her cancer, and in response Johnson & Johnson and Colgate-Palmolive filed…
-
Research Shows Chemotherapy Decision Should Consider Mesothelioma Cell Type
When malignant mesothelioma is diagnosed, one of the first steps that clinicians follow is the staging of the patient’s disease. This important step helps physicians better understand how far the cancer cells have spread within the body and is just one of many that helps to determine what protocol will serve the patient best. New…
-
Retrial Begins in California Mesothelioma Lawsuit Against Johnson & Johnson
It’s been just over a year since mesothelioma victim Carolyn Weirick told a California jury about her diagnosis with malignant mesothelioma, and why she believed that Johnson & Johnson’s Baby Powder had caused her development of the rare and fatal form of cancer. That trial ended with a deadlocked jury unable to agree on a…
-
Cancer Researchers See Iron as Potential Path to Mesothelioma Cell Death
“Death by iron” may sound like a line out of the show Game of Thrones, but according to cell biologist Xuejun Jiang of the Sloan Kettering Institute, it may actually be the key to preventing the formation of malignant mesothelioma tumors, and even to killing metastatic mesothelioma cells. Dr. Jiang and his colleagues have been investigating ferroptosis,…
-
Cancer Center in Tennessee First in U.S. to Offer New FDA-Approved Mesothelioma Treatment
Last May, the U.S. Food and Drug Administration announced that it had approved the use of the NovoTTF-100L System in combination with pemetrexed plus platinum-based chemotherapy for the first-line treatment of unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM). Now, West Cancer Center in Tennessee has announced that it will be the first oncology center…
-
Mesothelioma Patients With Genetic Mutation Have Greater Success With Chemotherapy
We’ve long known that our genes dictate characteristics like eye color and height, but a new study conducted by the National Cancer Institute is indicating that genes can also determine how well mesothelioma patients respond to chemotherapy. Raffit Hassan, M.D., a special investigator with the National Cancer Institute’s Center for Cancer Research, led the study…
-
Upcoming Meeting to Feature News on Latest Mesothelioma Study
Later this month, the European Society for Medical Oncology (ESMO) will be holding its annual meeting in Barcelona, Spain, and one of the most anticipated studies that will be presented is a malignant mesothelioma trial that pharmaceutical and biotech industry news site Vantage.com is saying “threatens to steal the limelight” from the rest of presentations scheduled…
-
Electrician’s Mesothelioma Lawsuit Allowed to Proceed, Despite Asbestos Company Objections
George C. Proctor died of malignant mesothelioma on March 23rd, 2019, just a year after he was first diagnosed with the rare form of cancer. Though he had little time between diagnosis and death, Mr. Proctor was able to file a mesothelioma lawsuit against several companies whose products he held responsible for exposing him to…
-
New Lymph Node Testing Can Save Patients From Unnecessary Mesothelioma Surgery
Though medical science has come a long way in its understanding of malignant mesothelioma, it still has a long way to go. The rare and deadly form of cancer that is caused by exposure to asbestos is notoriously difficult to treat. It can also be difficult to diagnose. With this in mind, researchers from Canada…
-
Treatment Disparities Among Mesothelioma Patients Discussed At Conference
The annual World Conference on Lung Cancer was held last week in Barcelona, Spain, and among the topics covered by international researchers and presenters was a little-discussed reality in treatment disparities among patients diagnosed with malignant mesothelioma. Emanuela Taioli, MD, director of the Institute for Translational Epidemiology and the Center for the Study of Thoracic…
-
Phase 2 Study of Novel Gene Therapy for Mesothelioma Begins at Baylor
Biotherapeutics company Momotaro-Gene has announced the beginning of a Phase 2 clinical trial on their innovative treatment for malignant mesothelioma. The study will analyze the efficacy of the company’s novel gene therapy called MTG201 combined with the PD-1 inhibitor nivolumab (Opdivo) on patients whose cancer has returned. Treatment being tested on patients who have relapsed…
-
Jury Finds J & J Caused Mesothelioma, Orders Payment of $37.2 Million to 4 Victims
After hearing weeks of testimony, a New Jersey jury has sided with four people who blame Johnson & Johnson’s baby powder and other talc-based powders for their malignant mesothelioma. The jury ordered the consumer giant to pay the victims — Douglas Barden, 65, David Etheridge, 57, D’Angela McNeill-George, 41, and Will Ronning, 46 — at…
-
Each Year, More 9/11 Survivors Die of Malignant Mesothelioma
Every year since 2001, the nation pauses to remember those who died in the terrorist attacks on the Pentagon and World Trade Center on September 11th. And every year, the number of actual victims of those attacks grows as a result of people dying from related diseases, including malignant mesothelioma. Many believe that by the…
-
New Early Lung Cancer Test May Help Diagnose Malignant Pleural Mesothelioma
When researchers at the 2019 World Conference on Lung Cancer announced they’d seen positive results from a new early lung cancer detection tool, it raised the hopes of mesothelioma physicians around the world. The rare and fatal form of lung cancer caused by exposure to asbestos is notoriously difficult to treat, and one of the…
-
Why Mesothelioma Patients Need Advance Care Planning
If you or someone you love has been diagnosed with malignant mesothelioma, there are an awful lot of decisions that need to be made about the type of medical treatments you wish to submit to. It is important to put thought into what you want done to help improve your situation. It makes equal sense…
-
Auto Mechanic Wins $8.4 Million Mesothelioma Verdict Against Ford Motor Co.
A St. Louis jury ordered Ford Motor Company to pay $8.433 million in compensation to lifelong resident Al Bennett and his wife Pam after hearing evidence that the company had exposed him to asbestos, leading to his diagnosis with malignant pleural mesothelioma. Mesothelioma is a fatal form of cancer that affects the lining of the…
-
Judge in Johnson & Johnson Mesothelioma Case Rebukes Company’s Attorney
Mesothelioma victims are often torn about whether to pursue legal action against the companies responsible for their illness: the idea of battling giant asbestos companies can be intimidating. But those affected by asbestos can take heart from what happened this week in a New Jersey courtroom. Middlesex County Superior Court Judge Anna C. Viscomi struck…
-
Chinese Mesothelioma Researchers Create Highly Accurate Tool to Predict Survival
When a person is diagnosed with malignant mesothelioma and informed that the condition is always considered terminal, one of the first questions that they ask is about how much time they have left. Now, a new visual tool created by cancer researchers at China’s Peking University may be able to provide a highly accurate answer,…
